Cargando…
Challenges and Considerations on Risk-Reducing Surgery in BRCA1/2 Patients with Advanced Breast Cancer
Cancer survivors harboring inherited pathogenic variants in the breast cancer (BC) susceptibility genes BRCA1 or BRCA2 are at increased risk of ovarian cancer (OC) and also of contralateral BC. For these women, risk-reducing surgery (RRS) may contribute to risk management. However, women with locall...
Autores principales: | Vasconcelos de Matos, Leonor, Fernandes, Leonor, Louro, Pedro, Plácido, Ana, Barros, Manuel, Vaz, Fátima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903283/ https://www.ncbi.nlm.nih.gov/pubmed/33466630 http://dx.doi.org/10.3390/curroncol28010050 |
Ejemplares similares
-
From Theory to Practice: Bone Health in Women with Early Breast Cancer Treated with Aromatase Inhibitors
por: Vasconcelos de Matos, Leonor, et al.
Publicado: (2021) -
Is There a Role for Risk-Reducing Bilateral Breast Surgery in BRCA1/2 Ovarian Cancer Survivors? An Observational Study
por: Oliveira, Daniela, et al.
Publicado: (2023) -
Sweet’s Syndrome Induced by Aromatase Inhibitor in the Treatment of Early Breast Cancer
por: Cardoso, Debora, et al.
Publicado: (2020) -
Endocrine therapy for the treatment of leptomeningeal carcinomatosis in luminal breast cancer: a comprehensive review
por: Fernandes, Leonor, et al.
Publicado: (2020) -
Unfolding the role of the PI3K/AKT/MTOR pathway in male breast cancer: A pragmatic appraisal
por: Vasconcelos de Matos, Leonor, et al.
Publicado: (2023)